8 Results

People

  1. Heelan
    Heelan
  2. Kelsen
    Kelsen
  3. Kris
    Kris
  4. Azzoli
    Azzoli
  5. Huang
    Huang
  6. Ilson
    Ilson
  7. Krug
    Krug
  8. Miller
    Miller
  9. Pao
    Pao
  10. Riely
    Riely

Groups

  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Center for Pancreatic Cancer Research (6)
  4. Gastrointestinal Oncology Service (6)
  5. Thoracic Oncology (3)
  6. DigITs Research Group (1)
  7. Genitourinary Oncology Service (1)
  8. Nursing (1)
  9. Surgery (1)
  10. Survivorship Research (1)
  1. "carcinoma, squamous cell"
  2. "Department of Medicine"
  3. "Robert Heelan"
Formats
  1. Journal Article (8)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Center for Pancreatic Cancer Research (6)
  4. Gastrointestinal Oncology Service (6)
  5. Thoracic Oncology (3)
  6. DigITs Research Group (1)

More Groups

People
  1. Robert Heelan (8)
  2. David Kelsen (6)
  3. Mark Kris (3)
  4. Christopher Azzoli (2)
  5. David Ilson (2)
  6. Gregory Riely (2)

More People

Years
  1. 2010 (1)
  2. 2007 (1)
  3. 2000 (1)
  4. 1995 (1)
  5. 1992 (1)
  6. 1986 (2)

More Years

Publications
  1. Cancer Treatment Reports (3)
  2. Cancer (2)
  3. Journal of Clinical Oncology (1)
  4. Journal of Thoracic Oncology (1)
  5. The Cancer Journal (1)
Publishers
  1. National Cancer Institute (3)
  2. Wiley Blackwell (2)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Inc. (1)
  5. Lippincott Williams & Wilkins (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer
    Journal Article

    Price, K. A.; Azzoli, C. G.; Krug, L. M.; Pietanza, M. C.; Rizvi, N. A.; Pao, W.; Kris, M. G.; Riely, G. J.; Heelan, R. T.; Arcila, M. E.; more...
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer
    Journal Article

    Milton, D. T.; Riely, G. J.; Azzoli, C. G.; Gomez, J. E.; Heelan, R. T.; Kris, M. G.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; more...
    Cancer (2007)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus
    Journal Article

    Ilson, D. H.; Forastiere, A.; Arquette, M.; Costa, F.; Heelan, R.; Huang, Y.; Kelsen, D. P.
    The Cancer Journal (2000)

    Fulltext@MSK | Save
  • A phase II trial of interferon alpha‐2A, 5‐fluorouracil, and cisplatin in patients with advanced esophageal carcinoma
    Journal Article

    Ilson, D. H.; Sirott, M.; Saltz, L.; Heelan, R.; Huang, Y.; Keresztes, R.; Kelsen, D. P.
    Cancer (1995)

    Fulltext@MSK | Save
  • Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer
    Journal Article

    Kelsen, D.; Lovett, D.; Wong, J.; Saltz, L.; Buckley, M.; Murray, P.; Heelan, R.; Lightdale, C.
    Journal of Clinical Oncology (1992)

    Fulltext@MSK | Save
  • Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus
    Journal Article

    Bajorin, D.; Kelsen, D.; Heelan, R.
    Cancer Treatment Reports (1986)

    Fulltext@MSK | Save
  • Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer
    Journal Article

    Kelsen, D. P.; Fein, R.; Coonley, C.; Heelan, R.; Bains, M.
    Cancer Treatment Reports (1986)

    Fulltext@MSK | Save
  • Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment
    Journal Article

    Kris, M. G.; Gralla, R. J.; Kalman, L. A.; Kelsen, D. P.; Casper, E. S.; Burke, M. T.; Groshen, S.; Cibas, I. R.; Bagin, R.; Heelan, R. T.
    Cancer Treatment Reports (1985)

    Fulltext@MSK | Save